ECA
MDT icon

Elevated Capital Advisors’s Medtronic MDT Stock Holding History

Elevated Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.34K Hold
81
– – ﹤0.01% 543
2026
Q1 		$7.02K Hold
81
– – ﹤0.01% 509
2025
Q4 		$7.78K Buy
+81
New +$7.87K ﹤0.01% 474

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Elevated Capital Advisors's MDT Position: Q2 2026 in Review

Elevated Capital Advisors held its Medtronic (MDT) position steady in Q2 2026 at 81 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

Elevated Capital Advisors first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.78K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Elevated Capital Advisors held 81 shares of Medtronic worth $6.34K as of Q2 2026.
  • Elevated Capital Advisors left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #543 holding.
  • Elevated Capital Advisors first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Medtronic position peaked at $7.78K in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.